Ponio, Winielyn A.
HRN: 24-68-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/10/2024
03/17/2024
IVT
500 Mg
Now Then Q 8 Hrs
TMSAF
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes